应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CTLT Catalent
休市中 08-23 16:00:00 EDT
59.44
+0.18
+0.30%
盘后
59.44
+0.00
0.00%
19:18 EDT
最高
59.49
最低
59.22
成交量
131.42万
今开
59.40
昨收
59.26
日振幅
0.45%
总市值
107.57亿
流通市值
106.91亿
总股本
1.81亿
成交额
7,804万
换手率
0.73%
流通股本
1.80亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
康泰伦特公司 预计每股收益47美分 - 财报前瞻
Reuters · 08-23 20:54
康泰伦特公司 预计每股收益47美分 - 财报前瞻
加拿大皇家银行:重申Catalent(CTLT.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由63.50美元调整至63.
智通财经 · 07-11
加拿大皇家银行:重申Catalent(CTLT.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由63.50美元调整至63.
巴克莱:维持Catalent(CTLT.US)评级
证券之星 · 06-29
巴克莱:维持Catalent(CTLT.US)评级
巴克莱:维持Catalent(CTLT.US)评级,由持股观望调整至持股观望评级, 目标价由47.00美元调整至63.00美元。
智通财经 · 06-28
巴克莱:维持Catalent(CTLT.US)评级,由持股观望调整至持股观望评级, 目标价由47.00美元调整至63.00美元。
美国研究综述-Alphabet、Equity Residential、Infinera
Reuters · 06-28
美国研究综述-Alphabet、Equity Residential、Infinera
Catalent:巴克莱银行将目标价从47美元上调至63美元。
智通财经 · 06-28
Catalent:巴克莱银行将目标价从47美元上调至63美元。
韦格威生产商诺和诺德将斥资 41 亿美元加强美国生产
Reuters · 06-25
韦格威生产商诺和诺德将斥资 41 亿美元加强美国生产
BUZZ-Sarepta 公司的杜兴氏基因疗法获 FDA 批准扩大使用范围,公司业绩大涨
Reuters · 06-21
BUZZ-Sarepta 公司的杜兴氏基因疗法获 FDA 批准扩大使用范围,公司业绩大涨
康泰伦特股东批准与诺和控股的交易
Reuters · 05-29
康泰伦特股东批准与诺和控股的交易
Catalent Inc-交易预计将于2024年日历年末完成
智通财经 · 05-29
Catalent Inc-交易预计将于2024年日历年末完成
Catalent股东批准与Novo Holdings的交易
智通财经 · 05-29
Catalent股东批准与Novo Holdings的交易
诺和诺德将发售四种欧元债 为收购Catalent工厂筹资知情人士透露,周二,多家银行将通过诺和诺德在荷兰的金融子公司,代表该公司出售4种期限的欧元计价债券,期限从2年到10年不等
格隆汇 · 05-14
诺和诺德将发售四种欧元债 为收购Catalent工厂筹资知情人士透露,周二,多家银行将通过诺和诺德在荷兰的金融子公司,代表该公司出售4种期限的欧元计价债券,期限从2年到10年不等
【为购厂筹资 诺和诺德(NVO.US)将发售4种欧元债】智通财经APP获悉,诺和诺德(NVO.US)将在两年多以来首次发行债券,为其重磅药物的增产计划提供资金。
智通财经 · 05-14
【为购厂筹资 诺和诺德(NVO.US)将发售4种欧元债】智通财经APP获悉,诺和诺德(NVO.US)将在两年多以来首次发行债券,为其重磅药物的增产计划提供资金。
【诺和诺德(NVO.US)两年来首次发行债券 以筹集扩张资金】智通财经APP获悉,诺和诺德(NVO.US)计划两年多来首次发行债券,为其扩大旗下畅销药物生产的大型项目提供资金。
智通财经 · 05-13
【诺和诺德(NVO.US)两年来首次发行债券 以筹集扩张资金】智通财经APP获悉,诺和诺德(NVO.US)计划两年多来首次发行债券,为其扩大旗下畅销药物生产的大型项目提供资金。
媒体-Ares 和 Blue Owl 牵头为康泰伦特交易提供 48 亿美元私人债务 - 彭博新闻社
Reuters · 04-06
媒体-Ares 和 Blue Owl 牵头为康泰伦特交易提供 48 亿美元私人债务 - 彭博新闻社
首席财务官表示,如果康泰伦特交易未完成,诺和诺德将提高资本支出
Reuters · 03-07
首席财务官表示,如果康泰伦特交易未完成,诺和诺德将提高资本支出
BUZZ-DNB 因收购 "改变游戏规则 "的康泰伦特而上调诺和诺德评级
Reuters · 03-04
BUZZ-DNB 因收购 "改变游戏规则 "的康泰伦特而上调诺和诺德评级
公司概况
公司名称:
Catalent
所属市场:
NYSE
上市日期:
--
主营业务:
Catalent, Inc.是全球领先的先进交付技术以及药物开发和制造解决方案的提供商。该公司的口服,注射,细胞和基因疗法以及细胞和呼吸道递送技术可满足制药行业的各种需求。
发行价格:
--
{"stockData":{"symbol":"CTLT","market":"US","secType":"STK","nameCN":"Catalent","latestPrice":59.44,"timestamp":1724443200000,"preClose":59.26,"halted":0,"volume":1314158,"hourTrading":{"tag":"盘后","latestPrice":59.44,"preClose":59.44,"latestTime":"19:18 EDT","volume":187085,"amount":11120332.28,"timestamp":1724455131879},"delay":0,"floatShares":179854805,"shares":180979849,"eps":-6.470426,"marketStatus":"休市中","marketStatusCode":7,"change":0.18,"latestTime":"08-23 16:00:00 EDT","open":59.4,"high":59.485,"low":59.22,"amount":78041802.435674,"amplitude":0.004472,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.470426,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1406779200000,"adjPreClose":59.26,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":59.44,"preClose":59.44,"latestTime":"19:18 EDT","volume":187085,"amount":11120332.28,"timestamp":1724455131879},"volumeRatio":1.1206234213352135,"impliedVol":0.0476,"impliedVolPercentile":0.0119},"requestUrl":"/m/hq/s/CTLT/wiki","defaultTab":"wiki","newsList":[{"id":"2461596189","title":"康泰伦特公司 预计每股收益47美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2461596189","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461596189?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:54","pubTimestamp":1724417664,"startTime":"0","endTime":"0","summary":" * 康泰伦特公司 将于8月27日公布截至2024年6月30日的财报() 预计季度收入将有所增长。* LSEG 分析师对康泰伦特公司的平均预期为每股收益 47 美分。* 华尔街对康泰伦特公司 12 个月目标价的中位数为 63.50 美元,高于其上次收盘价 59.26 美元。8月23日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康泰伦特公司 预计每股收益47美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTLT"],"gpt_icon":0},{"id":"2450645293","title":"加拿大皇家银行:重申Catalent(CTLT.US)评级,由与大盘持平调整至与大盘持平评级, 目标价由63.50美元调整至63.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450645293","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450645293?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:59","pubTimestamp":1720709990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4530","BK4588","BK4007","BK4585","CTLT"],"gpt_icon":0},{"id":"2447263852","title":"巴克莱:维持Catalent(CTLT.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2447263852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2447263852?lang=zh_cn&edition=full","pubTime":"2024-06-29 00:20","pubTimestamp":1719591624,"startTime":"0","endTime":"0","summary":"巴克莱:维持catalent(CTLT.US)评级,由持股观望调整至持股观望评级,目标价由47.00美元调整至63.00美元。Catalent(CTLT.US)公司简介:康泰伦特是一个合同开发和制造组织,简称CDMO。它的业务分为四个部分:生物制品;软凝胶和口腔技术;口腔和专业交付以及临床供应服务。其收入主要来自与制药客户的长期供应协议。该公司在产品的整个生命周期(从药物开发过程到商业供应)为药物、基于蛋白质的生物制剂、细胞和基因疗法以及消费者健康产品提供一系列的开发和制造解决方案,在四大洲拥有50多家工厂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062900253595e47a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062900253595e47a25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTLT"],"gpt_icon":0},{"id":"2446687504","title":"巴克莱:维持Catalent(CTLT.US)评级,由持股观望调整至持股观望评级, 目标价由47.00美元调整至63.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446687504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446687504?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:42","pubTimestamp":1719589355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4007","CTLT","BK4530","BK4588"],"gpt_icon":0},{"id":"2446582501","title":"美国研究综述-Alphabet、Equity Residential、Infinera","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582501","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446582501?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:16","pubTimestamp":1719577011,"startTime":"0","endTime":"0","summary":" 路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Alphabet、Equity Residential 和 Infinera。要闻 * Alphabet Inc :罗森布拉特证券公司将其评级从 \"买入 \"下调至 \"中性\"。* Cincinnati Financial Corp :花旗集团将其评级从 \"买入 \"上调至 \"买入 * Equity Residential :Piper Sandler将其评级从中性上调至增持 * 英飞朗 :Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DE","AMP","ARRY","CRL","BP","LU1280957306.USD","IE00BJTD4N35.SGD","LU0708995401.HKD","AFL","DAY","TXG","DLR","CALC","LU0109391861.USD","BWIN","CHPT","AGCO","CINF","CMG","ALSN","CHWY","T","APOG","CHK","BB","BHF","CRK","ELAN","LU0061475181.USD","AOSL","AFG","CRBG","BL","DAL","DLTR","LU2264538146.SGD","AVTR","LU0494093205.USD","CERT","EQH","LU0106831901.USD","ACCD","LU0128525929.USD","BKR","DCTH","AR","GOOGL","CTLT"],"gpt_icon":0},{"id":"2446503907","title":"Catalent:巴克莱银行将目标价从47美元上调至63美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446503907","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446503907?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:24","pubTimestamp":1719573891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4521","BK5152","BK4588","BK4530","BK4585","LU0047473722.SGD","LU0106831901.USD","BARC.UK","BCS","CTLT","LU0047473722.EUR","LU0550127509.SGD","BK4207","LU0161305163.EUR","LU1668664300.SGD"],"gpt_icon":0},{"id":"2446007600","title":"韦格威生产商诺和诺德将斥资 41 亿美元加强美国生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2446007600","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446007600?lang=zh_cn&edition=full","pubTime":"2024-06-25 02:15","pubTimestamp":1719252906,"startTime":"0","endTime":"0","summary":" Isabelle Yr Carlsson/Maggie Fick 路透6月24日 - 肥胖症药物生产商诺和诺德 周一表示,将斥资41亿美元在美国建造一座工厂,为其广受欢迎的减肥药Wegovy和糖尿病药物Ozempic灌装注射剂。诺和诺德公司于 31 年前开设了这家工厂。为了提高诺和诺德的Wegovy生产能力,诺和诺德的控股股东诺和诺德控股公司于今年2月宣布,将以165亿美元的价格收购美国大型合同药品生产商康泰伦特公司,后者是Wegovy的分包商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","NVO","BK4530","BK4585","CTLT","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4532"],"gpt_icon":0},{"id":"2445765135","title":"BUZZ-Sarepta 公司的杜兴氏基因疗法获 FDA 批准扩大使用范围,公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2445765135","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445765135?lang=zh_cn&edition=full","pubTime":"2024-06-21 22:36","pubTimestamp":1718980589,"startTime":"0","endTime":"0","summary":" 6月21日 - ** Sarepta Therapeutics 的股价在早盘交易中大涨约33%,创下三年多来的新高 ** 按目前水平计算,公司市值将增加近 40 亿美元 ** 周四晚些时候,美国食品和药物管理局批准 公司的基因疗法 Elevidys 用于遗传性进行性肌肉萎缩症患者的治疗。** 包括本交易日的涨幅在内,该公司股价今年累计上涨超过68%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","BK4566","GB00BDT5M118.USD","CTLT","SRPT","LU1720051017.SGD","LU1670628061.USD","BK4139","LU2125909247.SGD","LU2125909916.SGD","BK4121","BK4585","IE00B2B36J28.USD","IE0009355771.USD","BK4007","LU0114720955.EUR","LU1064131342.USD","LU1623119135.USD","TMO","LU0957791311.USD","LU1923622614.USD","LU2357305700.SGD","LU1280957306.USD","BK4581","LU2041044095.USD","LU0122379950.USD","LU1670627923.USD","LU0528227936.USD","LU1791710582.SGD","LU1989771016.USD","BUZZ","LU1923622291.USD","LU2264538146.SGD","IE00BFTCPJ56.SGD","LU2063271972.USD","LU0557290698.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","LU1712237335.SGD","LU0011850046.USD","LU1854103824.USD","BK4588","LU2125909759.SGD","LU1720051108.HKD","LU1791710400.SGD","BK4535","BK4530","LU0640476718.USD","IE0002141913.USD","LU0882574055.USD"],"gpt_icon":0},{"id":"2439015524","title":"康泰伦特股东批准与诺和控股的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2439015524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439015524?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:14","pubTimestamp":1716988484,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透5月29日 - 康泰伦特 周三称,其股东已投票通过了与诺和诺德 母公司诺和诺德控股(Novo Holdings)的交易。今年2月,Novo Holdings同意以165亿美元收购康泰伦特。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","NVO","BK4532","BK4588","BK4530","CTLT"],"gpt_icon":0},{"id":"2439587524","title":"Catalent Inc-交易预计将于2024年日历年末完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2439587524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439587524?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:07","pubTimestamp":1716988033,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4530","BK4007","BK4585","CTLT","BK4588"],"gpt_icon":0},{"id":"2439533524","title":"Catalent股东批准与Novo Holdings的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2439533524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439533524?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:07","pubTimestamp":1716988020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CTLT","BK4530","BK4007","BK4588","BK4585"],"gpt_icon":0},{"id":"2435515466","title":"诺和诺德将发售四种欧元债 为收购Catalent工厂筹资知情人士透露,周二,多家银行将通过诺和诺德在荷兰的金融子公司,代表该公司出售4种期限的欧元计价债券,期限从2年到10年不等","url":"https://stock-news.laohu8.com/highlight/detail?id=2435515466","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435515466?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:26","pubTimestamp":1715693185,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","BK4530","BK4588","NVO","159940","FXE","BK4585","161121","BK4532","EUO","CTLT","EURmain","MEURmain"],"gpt_icon":0},{"id":"2435594082","title":"【为购厂筹资 诺和诺德(NVO.US)将发售4种欧元债】智通财经APP获悉,诺和诺德(NVO.US)将在两年多以来首次发行债券,为其重磅药物的增产计划提供资金。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435594082","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435594082?lang=zh_cn&edition=full","pubTime":"2024-05-14 19:42","pubTimestamp":1715686953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","MEURmain","FXE","01477","BK4007","NVO","BK4585","BK1574","BK4532","BK4530","BK1191","CTLT","EURmain","EUO"],"gpt_icon":0},{"id":"2435237826","title":"【诺和诺德(NVO.US)两年来首次发行债券 以筹集扩张资金】智通财经APP获悉,诺和诺德(NVO.US)计划两年多来首次发行债券,为其扩大旗下畅销药物生产的大型项目提供资金。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435237826","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435237826?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:29","pubTimestamp":1715606949,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","161121","BK4530","EURmain","CTLT","BK4007","EUO","159940","BK4588","NVO","MEURmain","BK4585","FXE"],"gpt_icon":0},{"id":"2425519231","title":"媒体-Ares 和 Blue Owl 牵头为康泰伦特交易提供 48 亿美元私人债务 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2425519231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425519231?lang=zh_cn&edition=full","pubTime":"2024-04-06 04:47","pubTimestamp":1712350052,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 4月5日 - -- 来源链接: -- 注:路透社未核实此报道,不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTLT","BK4585","AACT.U","BK4530","BK4588"],"gpt_icon":0},{"id":"2417795077","title":"首席财务官表示,如果康泰伦特交易未完成,诺和诺德将提高资本支出","url":"https://stock-news.laohu8.com/highlight/detail?id=2417795077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417795077?lang=zh_cn&edition=full","pubTime":"2024-03-07 23:53","pubTimestamp":1709826819,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透社哥本哈根3月7日 - 丹麦制药公司诺和诺德 首席财务官卡斯滕-蒙克-克努森(Karsten Munk Knudsen)周四表示,如果公司不能完成计划中的康泰伦特 收购案,诺和诺德将增加资本支出,建设灌装-成品生产能力。Knudsen在诺和诺德的资本市场日上对分析师说,如果诺和诺德没有完成对康泰伦特的收购,诺和诺德还将与合同药品生产商进行更多的交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","BK4588","CTLT","BK4532","BK4530","NVO"],"gpt_icon":0},{"id":"2416114168","title":"BUZZ-DNB 因收购 \"改变游戏规则 \"的康泰伦特而上调诺和诺德评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2416114168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416114168?lang=zh_cn&edition=full","pubTime":"2024-03-04 20:06","pubTimestamp":1709553972,"startTime":"0","endTime":"0","summary":" 3月4日 - ** DNB Markets将诺和诺德 的评级从 \"持有 \"上调至 \"买入\",称其收购 ,主要生产分包商康泰伦特 将 \"改变游戏规则\",从2026年起,Wegovy的销售将由 \"需求驱动\"。** DNB表示,Wegovy的供应瓶颈在于灌装链,收购康泰伦特的三个灌装-成品生产基地有可能解决Wegovy的供应问题,并支持进一步的推广。** DNB 认为 Wegovy 的销量在 2026 年后将大幅增长,并预计在没有供应限制的情况下将会快速推广和吸收。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","NVO","LLY","DNB","CTLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.catalent.com","stockEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":0.0178},{"period":"3month","weight":0.0843},{"period":"6month","weight":0.0114},{"period":"1year","weight":0.3327},{"period":"ytd","weight":0.3229}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Catalent, Inc.是全球领先的先进交付技术以及药物开发和制造解决方案的提供商。该公司的口服,注射,细胞和基因疗法以及细胞和呼吸道递送技术可满足制药行业的各种需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.058226},{"month":2,"riseRate":0.6,"avgChangeRate":0.038189},{"month":3,"riseRate":0.4,"avgChangeRate":0.009076},{"month":4,"riseRate":0.6,"avgChangeRate":0.013795},{"month":5,"riseRate":0.5,"avgChangeRate":0.014479},{"month":6,"riseRate":0.6,"avgChangeRate":0.020877},{"month":7,"riseRate":0.8,"avgChangeRate":0.082712},{"month":8,"riseRate":0.636364,"avgChangeRate":0.007235},{"month":9,"riseRate":0.4,"avgChangeRate":-0.04074},{"month":10,"riseRate":0.6,"avgChangeRate":-0.028588},{"month":11,"riseRate":0.6,"avgChangeRate":0.01097},{"month":12,"riseRate":0.5,"avgChangeRate":0.002741}],"exchange":"NYSE","name":"Catalent","nameEN":"Catalent"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Catalent(CTLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Catalent,CTLT,Catalent股票,Catalent股票老虎,Catalent股票老虎国际,Catalent行情,Catalent股票行情,Catalent股价,Catalent股市,Catalent股票价格,Catalent股票交易,Catalent股票购买,Catalent股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Catalent(CTLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Catalent(CTLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}